[Significance of mediator agents in asthma in animal experiments and clinical practice].
D000818:Animals; D000937:Antigen-Antibody Reactions; D001249:Asthma / Q000378:metabolism / Q000503:physiopathology*; D012898:Autacoids / Q000502:physiology; D001920:Bradykinin / Q000502:physiology; D001980:Bronchi / Q000187:drug effects; D004205:Cromolyn Sodium / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D006168:Guinea Pigs; D006493:Heparin / Q000502:physiology; D006632:Histamine / Q000378:metabolism / Q000502:physiology*; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006636:Histamine Release; D006801:Humans; D011453:Prostaglandins / Q000502:physiology
D012898:Autacoids; D006634:Histamine H1 Antagonists; D011453:Prostaglandins; D006632:Histamine; D006493:Heparin; D004205:Cromolyn Sodium; D001920:Bradykinin; D004837:Epinephrine
Die Bedeutung von Mediatorstoffen für das Asthma im Tierexperiment und in der Klinik.